Novo Nordisk just announced price cuts for Ozempic and Wegovy, whose list prices as recently as last year were around $1,000 ...

As people’s bodies change due to GLP-1s, so does their spending across industries including fashion, restaurants, gyms and ...

Australia’s medicines regulator has issued a safety warning over the risk of suicidal thoughts and behaviour linked to drugs ...

Patients on popular GLP-1 weight-loss and diabetes jabs should be monitored for suicidal behaviour, the TGA says, while ...

The explosive rise of drugs like Ozempic and Mounjaro is shifting consumption patterns, health outcomes and pushing ...

The weight loss market has become one of the hottest areas in the pharmaceutical industry. Investors looking to capitalize on ...

The alarming trend spotted amongst GLP-1 users means some patients cannot lift their limbs due to nerve dysfunction.

Share on PinterestNovo Nordisk has announced the cessation of the Evoke trials, looking at whether GLP-1 drugs could help ...

Research is important to us for many reasons. Sometimes, for example, research results in a new treatment (e.g., Alexander ...

Meghan Trainor decided to quit drinking coffee after a psychic told her husband, Daryl Sabara, that her caffeine intake was ...

Semaglutide, the drug behind the blockbuster weight-loss jabs Ozempic and Wegovy, does not slow cognitive decline in people with early-stage Alzheimer's, according to two large new studies.

CHRISTMAS will be very merry for three million fat jab users — as they are likely to get drunk quickly. Doctors have issued a ...